As more Alzheimer’s research programs are terminated, check out our highlights from the latest neuroscience and neurology industry headlines.
Genetics are a risk factor for developing dementia due to Alzheimer’s disease and now several Alzheimer’s prevention trials are focused on individuals, who based on their age and genetic profile, are at high risk for developing the disease.
From novel biomarkers, to the potential use of the Zika virus as a tumor treatment, read our round-up of the biggest neuro-oncology news from the last year as we mark World Cancer Day.
From clinical trial results to major policy change announcements, here we present an overview of the latest industry news from the biggest players in neuroscience and neurology
Jeffrey C. Hall, Michael Rosbash and Michael W. Young receive the award for their work on the molecular mechanisms controlling circadian rhythms.